Vaccine row ‘proves Brexiteers made right decision’ says Daubney
When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.
The top eurocrat’s warning came as 16 member states continued to halt distribution of the AstraZeneca vaccine over unsubstantiated fears it causes blood clots. And an Express.co.uk analysis of EU data shows the bloc is sitting on a mountain of almost eight million unused doses of the Oxford-produced shot as a result. The decision by European capitals was derided as a “political one” as experts warned the move puts lives at risk.
Speaking at a news conference, Mrs Kyriakides said: “Even with the immense and regrettable challenges around production capacity and deliveries, there are reports of unused reservoirs of vaccines across the European Union.
“We currently see the proportions of available vaccine doses distributed range from 50-100 percent across member states.
“Every dose counts and every dose is providing a protective shield for our health workers, our elderly, or our vulnerable groups.”
European countries, including France, Italy, Spain and Germany, continue to suspend the use of the AstraZeneca vaccine despite the bloc’s medicines regulator insisting it is safe to rollout.
EU governments have used just 48 million doses out of the 62.2 million delivered to them, according to official data published by the European Centre for Disease Prevention and Control.
Nearly 15 million of those doses were supplied by UK-based drugs giant AstraZeneca, with more than 7.5 million of the unused vaccines now sitting unused in fridges across the bloc.
France and Germany, who have been blamed for the mass revolt, were found to be the worst offenders, having used less than half of their supplies of the Oxford jab.
The head of Italy’s medicines watchdog accused Paris and Berlin of playing politics amid a blazing row between AstraZeneca and the European Commission over the shortfalls in its deliveries to member states.
Nicola Magrini, director general of AIFA, fumed: “We got to the point of a suspension because several European countries, including Germany and France, preferred to interrupt vaccinations…to put them on hold in order to carry out checks. The choice is a political one.”
Italy has used two-thirds of the 1.5 million doses of coronavirus shipped to it by the Anglo-Swedish firm.
Italian MEP Paolo Borchia accused the influential capitals of “huffing and puffing” amid growing public anger over the slow rollout of jabs.
MUST READ: Britons furious as 16 European states suspend use of UK jab
He added: “I think that they’re exaggerating the AstraZeneca story – the biggest issue is that the EU is behind the UK and US in the vaccination campaign.”
Sixteen EU countries, including France, Germany, Portugal, Sweden Ireland, Italy, Spain, Denmark, Romania, Latvia, Austria, Lithuania, Estonia, the Netherlands, Luxembourg and Bulgaria, have all suspended use of the Oxford jab over fears it causes blood clots.
But Europe’s medical regulator the EMA has doubled down on claims that the benefits of the vaccine “outweigh the risk of side-effects”.
EMA hints at Germany and France over-reaction on AstraZeneca [VIDEO]
BBC reporter give crystal clear explanation of AstraZeneca farce [ANALYSIS]
Dutch election to decide EU future as Rutte eyes Merkel’s hot seat [REVEALED]
AstraZeneca: Expert slams ‘nonsense’ claims about vaccine
And EMA boss Emer Cooke warned member states that their persistent attacks on AstraZeneca jab.
She told a news conference: “At present there is no indication vaccination has caused these conditions. We’re still firmly convinced the benefits of the vaccine outweigh the risk of side-effects.
“We are worried that there may be an effect on the trust of the vaccines, but our job is to make sure the products that we authorised are safe and can be trusted by the European citizens.”
Source: Read Full Article